Yoshioka H, Ishida T, Atagi S, Tamiya A, et al. Randomized Phase II Trial of Amrubicin Plus Irinotecan Versus Cisplatin Plus Irinotecan in Chemo-naive Patients With Extensive-Disease Small-Cell Lung Cancer: Results of the Japan Multinational Trial Organization (JMTO) LC 08-01. Clin Lung Cancer 2024 Oct 1:S1525-7304(24)00197.
PMID: 39482146